Results: 14
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907
- By:
- Publication type:
- Article
Propofol mediates non‐small cell lung cancer growth in part by regulating circ_0003028‐related mechanisms.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1606, doi. 10.1111/1759-7714.14906
- By:
- Publication type:
- Article
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1640, doi. 10.1111/1759-7714.14913
- By:
- Publication type:
- Article
Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1635, doi. 10.1111/1759-7714.14909
- By:
- Publication type:
- Article
GTSE1 promotes the growth of NSCLC by regulating microtubule‐associated proteins through the ERK/MAPK pathway.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1624, doi. 10.1111/1759-7714.14908
- By:
- Publication type:
- Article
Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1644, doi. 10.1111/1759-7714.14914
- By:
- Publication type:
- Article
Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
- By:
- Publication type:
- Article
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1589, doi. 10.1111/1759-7714.14902
- By:
- Publication type:
- Article
RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor‐associated macrophages.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1581, doi. 10.1111/1759-7714.14901
- By:
- Publication type:
- Article
Survival and medical costs of non‐small cell lung cancer patients according to the first‐line treatment: An observational study using the Kyoto City Integrated Database.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1574, doi. 10.1111/1759-7714.14900
- By:
- Publication type:
- Article
The effects of inspiratory muscle training with pulmonary rehabilitation on NSCLC patients during radiation therapy: A pilot clinical study.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1567, doi. 10.1111/1759-7714.14899
- By:
- Publication type:
- Article
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1556, doi. 10.1111/1759-7714.14898
- By:
- Publication type:
- Article
Downregulation of circ_PLXND1 inhibits tumorigenesis of non‐small cell lung carcinoma via miR‐1287‐5p/ERBB3 axis.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1543, doi. 10.1111/1759-7714.14897
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1541, doi. 10.1111/1759-7714.14503
- Publication type:
- Article